Prosecution Insights
Last updated: August 18, 2026

Examiner: BENAVIDES, JENNIFER ANN

Tech Center 1700 • Art Units: 1649 1654 1675 1797

This examiner grants 51% of resolved cases

Performance Statistics

51.3%
Allow Rate
-13.7% vs TC avg
163
Total Applications
+48.6%
Interview Lift
1165
Avg Prosecution Days
Based on 117 resolved cases, 2023–2026

Rejection Statute Breakdown

3.4%
§101 Eligibility
13.9%
§102 Novelty
31.7%
§103 Obviousness
31.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17409589 METHODS OF TREATING CANCER Non-Final OA CITIUS PHARMACEUTICALS, INC.
18278797 Highly Potent M-CENK Cells And Methods Non-Final OA ImmunityBio, Inc.
18026746 METHODS OF TREATING AN INDIVIDUAL THAT HAS FAILED AN ANTI-PD-1/ANTI-PD-L1 THERAPY Final Rejection Dana-Farber Cancer Institute, Inc.
16982333 COMPOSITIONS AND METHODS FOR CANCER TREATMENT Final Rejection Dana-Farber Cancer Institute, Inc.
17779499 COMBINATION THERAPY FOR HEAD AND NECK CANCER Non-Final OA THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
19358181 METHODS OF TREATING TUMORS Non-Final OA Halozyme, Inc.
17482650 Stable Formulations of Programmed Death Receptor 1 (PD-1) Antibodies and Hyaluronidase Variants and Fragments Thereof and Methods of Use Thereof Non-Final OA Merck Sharp & Dohme LLC
17762354 NK ENGAGER COMPOUNDS THAT BIND VIRAL ANTIGENS AND METHODS OF USE Non-Final OA Regents of the University of Minnesota
17817178 THERAPEUTIC FRACTIONS AND PROTEINS FROM ASTHMA-PROTECTIVE FARM DUST Non-Final OA ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA
17413468 BARN DUST EXTRACT FOR THE PREVENTION AND TREATMENT OF DISEASES Non-Final OA The Arizona Board of Regents on Behalf of the University of Arizona

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month